MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.

@article{Perreault2003MRAW,
  title={MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.},
  author={Pierre Perreault and Mark A Edelman and Richard A. Baum and E. K. Yucel and Robert M. Weisskoff and Kohkan Shamsi and Emile R. Mohler},
  journal={Radiology},
  year={2003},
  volume={229 3},
  pages={811-20}
}
PURPOSE To evaluate the dose response and safety of gadofosveset trisodium-enhanced magnetic resonance (MR) angiography compared with nonenhanced two-dimensional time-of-flight MR angiography and with x-ray angiography as the standard. MATERIALS AND METHODS In this randomized, 20-center, double-blind study, 238 men and women who had peripheral vascular… CONTINUE READING